LRRK2 and Parkinson disease: When manifested, clinical expression of LRRK2-PD is usually similar to IPD and consists of late onset levodopa-responsive parkinsonism, typical complications of dopaminergic therapy, and nonmotor features including hyposmia and depression[8–15].